TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

We have developed C-STEMTM :  a proprietary technology for the mass-production of cell therapies.

Our offer

Cell therapy pipeline

A series of proprietary cell therapy programs for co-development or licensing

C-Stem™ platform

A cGMP-compatible mass-production platform for cell therapies

Latest news

  • Our CSO, Maxime Feyeux, contributed to a roundtable entitled “What breakthrough innovations to develop next-generation bioproduction factories ?” organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event....

  • Read the article ! ...

  • TreeFrog Therapeutics was Japan from the 10th to 21th of September 2019 to meet key academic and industry players. Notably, our team gave a presentation at the mecca of iPS : the Center for iPS Cell Research and Application (CiRA), Kyoto University. And on September 18th, Maxime Feyeux, our CSO, gave an oral presentation about C-Stem™ at the IMAPAC Cell Therapy World Asia conference in Tokyo ! ...

I am test text for Image with text shortcode.

TreeFrog Therapeutics I Stem Cell Company I Cell Therapy for all

TreeFrog Therapeutics is a French stem cell company aiming at supporting the advent and industrial development of stem cell therapies.